Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00079963 · ClinicalTrials.gov registry record · NA

Gender, Obesity, C-Reactive Protein, and Oxidative Stress

A NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
NA
Development phase
396
Enrollment target

NCT00079963 is a NA study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 396 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00079963, a NA study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
NA
Development phase
396 participants
Enrollment target

Study Summary

This randomized placebo-controlled trial will test whether supplementing with vitamins C and E can lower markers of inflammation and oxidative stress in healthy adults. We will examine whether one antioxidant vitamin is more effective than another, and whether gender or body fat influence the treatment effects. We will also determine whether gender, body fat, or menopausal status are associated with baseline concentrations of inflammation and oxidative stress markers.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Vitamin C
  • DIETARY_SUPPLEMENT Vitamin E

Trial Details

FieldValue
Enrollment Target 396 participants
Start Date 2004-04
Est. Completion 2008-03-24
Phase NA

What the Registry Record Tells You About NCT00079963

The ClinicalTrials.gov registry entry for NCT00079963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 396 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT00079963 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00079963 about?

NCT00079963 is a clinical study titled "Gender, Obesity, C-Reactive Protein, and Oxidative Stress". This randomized placebo-controlled trial will test whether supplementing with vitamins C and E can lower markers of inflammation and oxidative stress in healthy adults. We will examine whether one antioxidant vitamin is more effective than another, and whether gender or body fat influence the treatm...

What is the current status of trial NCT00079963?

This trial is currently completed. It is a NA study. The enrollment target is 396 participants. The study started on 2004-04. Estimated completion is 2008-03-24.

What interventions are being tested in trial NCT00079963?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin C (DIETARY_SUPPLEMENT), Vitamin E (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00079963?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.